A high degree of CD8+ and CD4+ T-cell infiltration in ESCC correlated with favorable clinical outcome, suggesting that tumor antigen-specific cellular immune response plays a role in the clinical course of the disease [16, 17]. Here, CD8A is linked to esophageal squamous cell carcinoma.